Abstract
Prostaglandins (PGs) are normally found in small or trace amounts in body tissues and cerebrospinal fluid (CSF) in the absence of stimulation. A wide variety of stimuli activate the enzyme phospholipase A2 of cell membranes to release arachidonic acid [cis-5, 8, 11, 14-icosatetraenoic acid (AA)], which is the main precursor of PGs in man.56 This lipid contains 20 carbons and 4 double bonds (C20:4) and is rapidly converted to oxygenated products by two distinct pathways. One pathway involves the enzyme lipoxygenase, which forms a number of unstable compounds (hydroperoxyarachidonic acids) of which little is known, but that may play a role in leukotaxis along with the PGs.73 Lipoxygenase is apparently found only in platelets, lungs, and white cells. The other pathway involves the enzyme cyclooxygenase (prostaglandin synthetase), which produces from AA the endoperoxide PGs (PGG2 and PGH2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abdel-Halim, M. S., Eckstedt, J., Anggard, E.: Determination of prostaglandin F2α, E2/ D2 and 6-Keto-Fiα in human cerebrospinal fluid, Prostaglandins17: 405–409, 1979.
Abdel-Halim, M. S., Hamberg, M., Sjoquist, B., Anggard, E.: Identificatioin of prostaglandin D2 as a major prostaglandin in homogenates of rat brain. Prostaglandins14: 633–643, 1977.
Aizawa, Y., Yamada, K.: Determination of prostaglandin F2α and E2 contents in human cerebrospinal fluid by the radioisotope dilution method. Prostaglandins11: 43–50, 1976.
Allen, G. S., Gross, C. J., French, L. A., Chou, S. N.: Cerebral vasospasm. 5. In vitro contractile activity of vasoactive agents including human CSF on human basilar and anterior cerebral arteries.J. Neurosurg. 44: 594–600, 1976.
Allen, G. S., Henderson, L. M., Chou, S. N., French, L. A.: Cerebral vasospasm. In vitro contractile activity of vasoactive agents on canine basilar and middle cerebral arteries. J. Neurosurg. 40: 433–441, 1974.
Bito, L. Z., Baroody, R.: Concentrative accumulation of 3 H-prostaglandins by some rabbit tissues in vitro: The chemical nature of the accumulated 3 H-labelled substances. Prostaglandins7: 131–140, 1974.
Bosisio, E., Galli, C., Galli, G., Nicosia, C., Spag-Nuolo, C., TosI, L.: Correlation between release of free arachidonic acid and prostaglandin formation in brain cortex and cerebellum. Prostaglandins11: 773–781, 1976.
Boullin, D. J., Bunting, S., Blaso, W. P., Hunt, T. M., Moncada, S.: Responses of human and baboon arteries to prostaglandin endoperoxides and biologically generated and synthetic prostacyclin: Their relevance to arterial vasospasm in man. Br. J. Pharmacol. 7: 139–147, 1979.
Boullin, D. J., Mohan, J., Grahame-Smith, D. G.: Evidence for the presence of a vasoactive substance (possibly involved in the aetiology of cerebral arterial spasm) in cerebrospinal fluid from patients with subarachnoid hemorrhage. J. Neurol. Neurosurg. Psychiatry39: 756–766, 1976.
Bradley, P. B., Samuels, G. M. R., Shaw, J. E.: Correlation between prostaglandin release from cerebral cortex of cats with electrocorticogram following stimulation of the reticular formation. Br. J. Pharmacol. 37: 151–157, 1969.
Carasso, R. L., Vardi, J., Rabay, J. M., Zor, U., Streifler, M.: Measurement of prostaglandin E2 in cerebrospinal fluid in patients suffering from stroke. J. Neurol. Neurosurg. Psychiatry40: 967–969, 1977.
Carlson, L. A., Ekelund, L. G., Oro, L.: Clinical and metabolic effects of different doses of prostaglandin E1 in man. Acta Med. Scand. 183: 423–430, 1968.
Chapleau, C. E., White, R. P.: Effects of prostacyclin on the canine isolated basilar artery. Prostaglandins17: 573–580, 1979.
Chapleau, C. E., White, R. P., Robertson, J. T.: Effects of prostaglandin synthetase inhibitors (PSI) on contractions induced by arachidonate, prostaglandin F2α and serotonin in basilar arteries. Fed. Proc. Fed. Am. Soc. Exp. Biol. 38:359, 1979 (abstract).
Chapleau, C. E., White, R. P., Robertson, J. T.: Cerebral vasospasm: Effects of prostaglandin synthetase inhibitors in vitro. Neurosurgery6: 155–158, 1980.
Chapleau, C. E., White, R. P., Robertson, J. T.: Cerebral vasodilation and prostacyclin: The effects of aspirin and meclofenamate in vitro. J. Neurosurg. 53: 188–192, 1980.
Cranston, W. I.: Central mechanisms of fever. Fed. Proc. Fed. Am. Soc. Exp. Biol. 38: 49–51, 1979.
Davson, H.: The blood-brain barrier. J. Physiol. 255: 1–28, 1976.
Didisheim, P., Fuster, V.: Actions and clinical status of platelet-suppressive agents. Semin. Hematol. 15: 55–72, 1978.
Feldberg, W.: Fever, prostaglandins, and antipyretics. In Robinson, H. J., Vane, J. R., (eds.): Prostaglandin Synthetase Inhibitors. New York, Raven Press, 1974, pp. 197–203.
Feldberg, W., Myers, R. D.: Appearance of 5-hy-droxytryptamine and an unidentified pharmacologically active lipid acid in effluent from perfused cerebral ventricles. J. Physiol. (London)184: 837–855, 1966.
Flower, R. J.: Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev. 26: 33–67, 1974.
Flower, R. J., Blackwell, G. J.: The importance of phospholipase-A2 in prostaglandin biosynthesis. Biochem. Pharmacol. 25: 285–291, 1976.
Fozard, J. R.: The animal pharmacology of drugs used in the treatment of migraine. J. Pharm. Pharmacol. 27: 297–321, 1975.
Frolich, J. C.: Gas chromatography-mass spectrometry of prostaglandins. In Ramwell, P. (ed.): Prostaglandins, Vol. 3. New York, Plenum Press, 1977, pp. 1–39.
Furlow, T. W., Bass, N. H.: Stroke in rats produced by carotid injections of sodium arachidonate. Science187: 658–660, 1975.
Furlow, T. W., Hallenbeck, J. M.: Indomethacin prevents impaired perfusion of the dog’s brain after global ischemia. Stroke9: 591–594, 1978.
Gorman, R. R.: Prostaglandins, thromboxanes, and prostacyclin. Int. Rev. Biochem. 20: 81–107, 1978.
Gorman, R. R.: Modulation of human platelet function by prostacyclin and thromboxane A2. Fed. Proc. Fed. Am. Soc. Exp. Biol. 38: 83–88, 1979.
Granstrom, E., Kindahl, H.: Radioimmunoassay of prostaglandins and thromboxanes. In Frolich, J. C. (ed.): Advances in Prostaglandin and Thromboxane Research, Vol. 5. New York, Raven Press, 1978, pp. 119–210.
Granstrom, E., Samuelsson, B.: Quantitative measurement of prostaglandins and thromboxanes: General considerations. In Frolich, J. C. (ed.): Advances in Prostaglandin and Thromboxane Research, Vol. 5. New York, Raven Press, 1978, pp. 1–13.
Green, K., Hamberg, M., Samuelsson, B., Frolich, J. C.: Extraction and chromatographic procedures for purification of prostaglandins, thromboxanes, prostacyclin, and their metabolites. In Frolich, J. C. (ed.): Advances in Prostaglandin and Thromboxane Research, Vol. 5. New York, Raven Press, 1978, pp. 15–38.
Green, K., Hamberg, M., Samuelsson, B., Frolich, J. C.: Measurement of prostaglandins, thromboxanes, prostacyclin, and their metabolites by gas-liquid chromatography-mass spectrometry. In Frolich, J. C. (ed.): Advances in Prostaglandin and Thromboxane Research, Vol. 5. New York, Raven Press, 1978, pp. 39–94.
Gryglewski, R. J., Dorbut, R., Ocetkiewicz, A., Splawinski, J., Wojtaszek, B., Swies, J.: Lungs as a generator of prostacyclin—hypothesis on physiological significance. Arch. Pharmacol. 304: 45–50, 1978.
Hagen, A. A., Gerber, J. N., Sweeley, C. C., White, R. P., Robertson, J. T.: Levels and disappearance of prostaglandin F2α in cerebral spinal fluid: A clinical and experimental study. Stroke8: 672–675, 1977.
Hagen, A. A., Gerber, J. N., Sweeley, C. C., White, R. P., Robertson, J. T.: Pleocytosis and elevation of prostaglandin F2α and E2 in cerebrospinal fluid following intracisternal injection of thrombin. Stroke8: 236–238, 1977.
Hagen, A. A., White, R. P., Robertson, J. T.: Synthesis of prostaglandins and thromboxane B2 by cerebral arteries. Stroke10: 306–309, 1979.
Hallenbeck, J. M., Leitch, D. R., Dutka, A. J., Greenbaum, L. J., Mckee, A. E.: Prostaglandin I2, indomethacin, and heparin promote postischemic neuronal recovery in dogs. Ann. Neurol. 12: 145–156, 1982.
Helrich, M., Papper, E. M., Brodie, B. B., Fink, M., Rovenstine, E. A.: The fate of intrathecal procaine and the spinal fluid level required for surgical anesthesia. J. Pharmacol. 100: 78–82, 1950.
Herman, A. G., Moncada, S., Vane, J. R.: Formation of prostacyclin (PGI2) by different layers of the arterial wall. Arch. Int. Pharmacodyn. Ther. 227: 162–163, 1977.
Heuser, D., Fieschi, C., Volante, F.: Platelet emboli and focal cerebral edema: An experimental study on the circulatory and metabolic effects of intracarotid infusion of ADP and arachidonic acid in rabbits. In Cervös-Navarro, J. (ed.): The Cerebral Vessel Wall. New York, Raven Press, 1976, pp. 149–156.
Hoff, J. T., Smith, A. L., Hankinson, H. L., Nielsen, S. L.: Barbiturate protection from cerebral infarction in primates. Stroke6: 28–33, 1975.
Holmes, S. W.: The spontaneous release of prostaglandins into the cerebral ventricles of the dog and the effect of external factors on this release. Br. J. Pharmacol. 38: 653–658, 1970.
Holmes, S. W., Horton, E. W.: The identification of four prostaglandins in dog brain and their regional distribution in the central nervous system. J. Physiol. 195: 731–741, 1978.
Horrobin, D. F.: Hypothesis: Prostaglandins and migraine. Headache17: 113–117, 1977.
Horton, E. W.: Prostaglandins: Monographs on Endocrinology. New York, Springer-Verlag, 1972, pp. 117–147.
Jarman, D. A., Duboulay, G. H., Kendall, B., Boul-Lin, D. J.: Responses of baboon cerebral and extracerebral arteries to prostacyclin and prostaglandin endoperoxide in vitro and in vivo. J. Neurol. Neurosurg. Psychiatry42: 677–686, 1979.
Jonsson, H. T., Daniell, H. B.: Altered levels of PGF in cat spinal cord tissue following traumatic injury. Prostaglandins11: 51–61, 1976.
Kataoka, K., Ramwell, P. W., Jessup, S.: Prostaglandins: Localization in subcellular particles of rat cerebral cortex. Science157: 1187–1189, 1967.
Katzman, R.: Cerebrospinal fluid physiology: Role of secretory and mediated transport system. In Tower, D. B. (ed.): The Nervous System, Vol. 1, The Basic Neurosciences. New York, Raven Press, 1975, pp. 291–297.
Landaw, I. S., Young, C. W.: Measurement of prostaglandin F2α levels in cerebrospinal fluid of febrile and afebrile patients with advanced cancer. Prostaglandins14: 343–353, 1977.
LA Torre, E., Patrono, C., Fortuna, A., GROSSI-BEL-LONI, D.: Role of prostaglandin F2 in human cerebral vasospasm. J. Neurosurg. 41: 293–299, 1974.
Leslie, C. A., Levine, L.: Evidence for the presence of a prostaglandin E2-9-keto reductase in rat organs. Biochem. Biophys. Res. Commun. 52: 717–721, 1973.
Levin, E., Sepulveda, F. V., Yudilevich, D. L.: Pial vessel transport of substances from cerebrospinal fluid to blood. Nature (London)249: 266–268, 1974.
Levine, L., van Vunakis, H.: Antigenic activity of prostaglandins. Biochem. Biophys. Res. Commun. 41: 1171–1177, 1970.
Mathe, A. A., Levy, M. L, Davis, B. M., Horvath, T. B., Davis, K. L.: Levels of PGE2 metabolite in CSF of patients with schizophrenia, depression and Alzheimer’s disease. Prog. Abstr. Soc. Biol. Psychiat. May 12–16, p. 93, 1982.
Mathe, A. A., Sedvall, G., Wiesel, F. A., Nyback, H.: Increased content of immunoreactive prostaglandin E in cerebrospinal fluid of patients with schizophrenia. Lancet1: 16–18, 1980.
Mcgiff, J. C., Malik, K. U., Terragno, N. A.: Prostaglandins as determinants of vascular reactivity. Fed. Proc. Fed. Am. Soc. Exp. Biol. 35: 2382–2387, 1976.
Moncada, S., Vane, J. R.: Arachidonic acid metabolites and the interactions between platelets and blood vessel walls. N. Engl. J. Med. 300: 1142–1147, 1979.
Moncada, S., Vane, J. R.: The role of prostacyclin in vascular tissue. Fed. Proc. Fed. Am. Soc. Exp. Biol. 38: 66–71, 1979.
Morgan, H., White, R. P., Pennink, M., Robertson, J. T.: Prostaglandins and experimental cerebral vasospasm. Surg. Forum23: 447–448, 1972.
Nickander, R., Mcmahan, F. G., Ridolfo, A. S.: Nonsteroidal anti-inflammatory agents. Annu. Rev. Pharmacol. 19: 469–490, 1979.
Olesen, J.: Effect of intracarotid prostaglandin E1 on regional cerebral blood flow in man. Stroke7: 566–569, 1976.
Pace-Asciak, C. R., Rangaraj, G.: Prostaglandin in biosynthesis and catabolism in the developing fetal sheep brain. J. Biol. Chem. 251: 3381–3385, 1976.
Pennink, M., White, R. P., Crockarell, J. R., Robertson, J. T.: Role of prostaglandin F2α in the genesis of experimental cerebral vasospasm: Angiographic study in dogs. J. Neurosurg. 37: 398–406, 1972.
Philipp-Dormston, W. K., Siefert, R.: Prostaglandins in cerebrospinal fluid of patients during various infectious diseases. Klin. Wochenschr. 53: 1167–1168, 1975.
Pickard, J. D., Mackenzie, E. T.: Inhibition of prostaglandin synthesis and the response of baboon cerebral circulation to carbon dioxide. Nature (London) New Biol. 245: 187–188, 1973.
Pickard, J. D., Macdonell, L. A., Mackenzie, E. T., Harper, A. M.: Response of the cerebral circulation in baboons to changing perfusion pressure after indomethacin. Circ. Res. 40: 198–203, 1977.
Pong, S. S., Levine, L.: Prostaglandin biosynthesis and metabolism as measured by radioimmunoassay. In Ramwell, P. (ed.): Prostaglandins, Vol. 3. New York, Plenum Press, 1977, pp. 41–76.
Potts, W. J., East, P. F., Landry, D., Dixon, J. P.: The effects of prostaglandin E2 on conditioned avoidance response behavior and the electroencephalogram. Adv. Biosci. 9: 489–494, 1973.
Prioleau, G. R., Chan, P. H., Fishman, R. H., Wilson, C. B.: In vivo study of the pathophysiology of brain edema. Program Abstract, Congress of Neurological Surgeons, pp. 124-125, 1979.
Ramwell, P. W., Shaw, J. E.: Spontaneous and evoked release of prostaglandins from cerebral cortex of anesthetized cats. Am. J. Physiol. 211: 125–134, 1966.
Rosenblum, W. I., EL-SABBAN, F.: Topical prostacyclin (PGI2) inhibits platelet aggregation in pial venules of the mouse. Stroke10: 399–401, 1979.
Rubin, R. P., Laychock, S. G.: Prostaglandins and calcium-membrane interactions in secretory glands. Ann. N. Y. Acad. Sci. 307: 377–390, 1978.
Runkel, R., Chaplin, M., Boost, G., Segre, E., for-Chielli, E.: Absorption, distribution, metabolism and excretion of naproxen in various laboratory animals and human subjects. J. Pharmaceut. Sci. 61: 703–708, 1972.
Shibuya, E., Masuda, K., Izawa, Y.: Effects of prostaglandins on leukocyte migration. Prostaglandins12: 165–174, 1976.
Toda, N., Miyazaki, M.: Responses of isolated dog cerebral and peripheral arteries to prostaglandins after application of aspirin and polyphloretin phosphate. Stroke9: 490–498, 1978.
Vane, J. R.: Mode of action of aspirin and similar compounds. In Robinson, H. J., Vane, J. R. (eds.): Prostaglandin Synthetase Inhibitors. New York, Raven Press, 1974, pp. 155–163.
Vardi, Y., Rabey, I. M., Streifler, M., Schwartz, A., Lindner, H. R., Zor, U.: Migraine attacks: Allievia-tion by an inhibitor of prostaglandin synthesis and action. Neurol. (Minneapolis)26: 447–450, 1976.
Vlahav, V., Betz, E.: Effects of indomethacin and D600 on the smooth muscle of pial vessels. In Cervos-Navarro, J. (ed.): Pathology of Cerebral Microcirculation. Berlin, Walter de Gruzter, 1974, pp. 130–136.
White, R. P.: Multiplex origins of vasospasm. In Price T. R., Nelson, E. (eds.): Cerebrovascular Disease, 11th Princeton Conference. New York, Raven Press, 1979, pp. 307–319.
White, R. P., Chapleau, C. E., Robertson, J. T.: Cerebral arterial contractions induced by human and bovine thrombin. Stroke11: 363–368, 1980.
White, R. P., Hagen, A. A., Morgan, H., Dawson, W. N., Robertson, J. T.: Experimental study on the genesis of cerebral vasospasm. Stroke6: 52–57, 1975.
White, R. P., Hagen, A. A., Robertson, J. T.: Effect of nonsteroid anti-inflammatory drugs on subarachnoid hemorrhage in dogs. J. Neurosurg. 51: 164–171, 1979.
Wilkinson, M.: The treatment of acute migraine attacks. Headache15: 291–292, 1976.
Wiseman, E. H., Chiani, J.: Anti-inflammatory and pharmacokinetic properties of sudoxicam N-(2-thia-zolyl)-4-hydroxy-2-methyl-2H-l, 2-benzothiazine-3-carboxamide 1, 1-dioxide. Biochem. Pharmacol. 21: 2323–2334, 1972.
Wolfe, L. S., Coceani, F.: The role of prostaglandins in the central nervous system. Annu. Rev. Physiol. 41: 669–684, 1979.
Wolfe, L. S., Coceani, F., Pace-Asciak, C.: Brain prostaglandins and studies of the action of prostaglandins on the isolated rat stomach. In Bergstrom, S., Samuelsson, B., (eds.): Prostaglandins: Nobel Symposium, 2nd ed. Stockholm, Almqvist and Wiksell, 1967, pp. 215–276.
Wolfe, L. S., Mamer, O. A.: Measurement of prostaglandin F2α levels in human cerebrospinal fluid in normal and pathological conditions. Prostaglandins9: 183–192, 1975.
Wolfe, L. S., Rostworowski, K., Marion, J.: Endogenous formation of the prostaglandin endope-roxide metabolite, thromboxane B2, by brain tissue. Biochem. Biophys. Res. Commun. 70: 907–913, 1976.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this chapter
Cite this chapter
White, R.P., Hagen, A.A., Robertson, J.T. (1983). Prostaglandins in Cerebrospinal Fluid. In: Wood, J.H. (eds) Neurobiology of Cerebrospinal Fluid 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9269-3_35
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9269-3_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9271-6
Online ISBN: 978-1-4615-9269-3
eBook Packages: Springer Book Archive